STAMFORD, Conn.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq:DCTH) today announced the appointment of Jonathan J. Lewis, MD, PhD to the Company’s Board of Directors. Dr. Lewis is Chief Executive Officer of ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a developer of novel cancer therapeutics with three product candidates in clinical trials.
